Pay in 4 interest-free payments of $5.92 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
The primary endpoint, a blinded assessment of the percentage over target (that is, time with dyskinesia or bradykinesia), recorded by home actimetry using a wristwatch, was significantly reduced on A-dopamine compared with that on oral treatment alone ( P = 0.027), with a median within-patient difference of 10.4 (Hedge g = 0.62 (95% confidence interval: 1.43, 0.08))
These may include increased thirst and urination, increased appetite, and potential risks to liver function
Easy to order, easy to use
This product is supplied exclusively for scientific laboratory
US$ 24.01
US$ 29.37
US$ 29.49
